diabetic peripheral neuropathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)ages between 18 and 70 years; 2)in accordance with the diagnostic criteria of the World Health Organization for diabetes in 1999; 3)HbA1c 3; 10)More than one of the four symptoms of TSS must appear continuously in the past 3 months; 11)Compliance with medication and treatment during the introduction period 85-100%.
Exclusion criteria
Exclusion criteria: 1)Patients with symptomatic peripheral vascular disease, active foot ulcers and / or previous amputation; 2)Drug and / or alcohol dependence, mental illness; 3)The skin of the site treated by ultrasound is damaged or broken; 4)Use large doses of painkillers (such as glucocorticoids) or illegal drugs (such as opioids) before screening and ultrasound treatment; 5)bleeding tendency disease; 6)Malignant tumor of any organ system within 5 years; 7) The patient underwent surgery within 4 weeks before signing the informed consent form, or major surgical operations were planned during the study; 8)Important medical issues, including uncontrollable hypertension (BP = 180 / 120mmHg), refractory heart failure, unstable arrhythmias, unstable symptomatic coronary artery ischemia, or any other disease that researchers believe may impair the patient's immune function; 9)Women with low immunity during pregnancy and lactation; 10)People with previous history of mental illness or cognitive impairment; 11)Participate in other clinical researchers at the same time. 12) Patients who are unable to communicate with the investigator or staff.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TSS; | — |
Secondary
| Measure | Time frame |
|---|---|
| NIS;Nerve conduction velocity;Vibration threshold; | — |
Countries
China
Contacts
Shanghai Jiao Tong University School of Medicine Affiliated Sixth People’s Hospital